Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Eferl

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
JAK-STAT|September 24, 2013
CCL2 at the crossroad of cancer metastasisRobert Eferl
Journal of Hepatology|August 14, 2012
A dual role for interferon γ signalling in hepatocellular carcinomaRobert Eferl
Gut|November 14, 2013
p21Waf1/Cip1 revisited: oncogenic function in hepatocellular carcinomaDaniel Goldenberg, Robert Eferl
Gut|January 7, 2017
CDK4/6 inhibition and sorafenib: a ménage à deux in HCC therapy?Diego Calvisi, Robert Eferl
Gut|May 7, 2017
Chromosomal instability in HCC: a key function for checkpoint kinase 2Robert Eferl, Michael Trauner
Nature Reviews. Cancer|December 12, 2003
AP-1: a double-edged sword in tumorigenesisRobert Eferl, Erwin F Wagner
Immunological Reviews|November 30, 2005
Fos/AP-1 proteins in bone and the immune systemErwin F Wagner, Robert Eferl
Hepatic Oncology|September 8, 2018
STAT3 in hepatocellular carcinoma: new perspectivesJasmin Svinka, Wolfgang Mikulits, Robert Eferl
Drug Discovery Today. Disease Models|May 12, 2012
Paulina Rampetsreiter, Emilio Casanova, Robert Eferl
Cytokine|November 2, 2022
Type I and II interferon signaling in colorectal cancer liver metastasisBernadette Mödl, Stefan Moritsch, Daniela Zwolanek, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
JAK-STAT|September 24, 2013
CCL2 at the crossroad of cancer metastasisRobert Eferl
Journal of Hepatology|August 14, 2012
A dual role for interferon γ signalling in hepatocellular carcinomaRobert Eferl
Gut|November 14, 2013
p21Waf1/Cip1 revisited: oncogenic function in hepatocellular carcinomaDaniel Goldenberg, Robert Eferl
Gut|January 7, 2017
CDK4/6 inhibition and sorafenib: a ménage à deux in HCC therapy?Diego Calvisi, Robert Eferl
Gut|May 7, 2017
Chromosomal instability in HCC: a key function for checkpoint kinase 2Robert Eferl, Michael Trauner
Nature Reviews. Cancer|December 12, 2003
AP-1: a double-edged sword in tumorigenesisRobert Eferl, Erwin F Wagner
Immunological Reviews|November 30, 2005
Fos/AP-1 proteins in bone and the immune systemErwin F Wagner, Robert Eferl
Hepatic Oncology|September 8, 2018
STAT3 in hepatocellular carcinoma: new perspectivesJasmin Svinka, Wolfgang Mikulits, Robert Eferl
Drug Discovery Today. Disease Models|May 12, 2012
Paulina Rampetsreiter, Emilio Casanova, Robert Eferl
Cytokine|November 2, 2022
Type I and II interferon signaling in colorectal cancer liver metastasisBernadette Mödl, Stefan Moritsch, Daniela Zwolanek, et al.
Pageof 8